Neurofibromatosis Drugs Market Strategic Developments and Forecast 2034
Growing investment in rare disease drug development is strengthening the Neurofibromatosis Drugs Market. Governments, research organizations, patient groups, and industry participants are contributing to efforts aimed at improving treatment options for individuals affected by these disorders. The global Neurofibromatosis Drugs Market was valued at US$ 3.45 Billion in 2025 and is expected to...
0 Comentários 0 Compartilhamentos 72 Visualizações 0 Anterior